GlassScriptPhysician profile
Timothy A Barnes
NPI 1699731240
$2,738.30
in general payments reported to CMS, 2019-2025
27 companies · $843 in 2025
The $843 reported for 2025 was more than what 80% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $492 · 2022: $416 · 2023: $295 · 2024: $692 · 2025: $843.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,745 · Education: $85.05.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,745.33 |
| Education | $85.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $590.00 | 2022-2025 | |
| Astellas Pharma US INC | $368.77 | 2021-2025 | Xtandi |
| Janssen Biotech, INC. | $247.48 | 2021-2025 | Erleada, Balversa, Akeega |
| Allergan, INC. | $227.68 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $214.56 | 2021-2025 | |
| Antares Pharma, INC. | $177.54 | 2022-2025 | Xyosted, Tlando, Nocdurna |
| Endo Pharmaceuticals INC. | $121.57 | 2021-2023 | Xiaflex |
| Pfizer INC. | $107.96 | 2023-2025 | |
| Procept Biorobotics Corporation | $89.77 | 2024-2025 | Aquabeam System |
| Halozyme INC | $79.74 | 2023 | |
| Progenics Pharmaceuticals, INC. | $77.42 | 2022-2025 | Pylarify |
| Urogen Pharma, INC. | $66.25 | 2022-2025 | |
| Endo USA, INC. | $52.44 | 2024-2025 | Xiaflex |
| Myovant Sciences INC. | $45.37 | 2021-2022 | |
| Immunitybio, INC. | $32.26 | 2025 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urovant Sciences INC | $31.36 | 2021-2022 | |
| Dendreon Pharmaceuticals LLC | $30.54 | 2021 | |
| Novartis Pharmaceuticals Corporation | $26.28 | 2025 | |
| Laborie Medical Technologies Corp. | $21.30 | 2025 | |
| Axonics, INC. | $20.69 | 2024 | Axonics |
| Tolmar Pharmaceuticals, INC. | $20.00 | 2021 | |
| Sumitomo Pharma America, INC. | $19.83 | 2024 | Orgovyx |
| Boston Scientific Corporation | $19.78 | 2024 | Rezum Generator |
| Coloplast Corp | $16.79 | 2024 | |
| 180 Medical, INC. | $16.39 | 2025 | Gentlecath |
| Verity Pharmaceuticals INC. | $14.04 | 2025 | Tlando |
| Travere Therapeutics, INC. | $2.49 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Barnes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.